Expression of Scer\GAL4GMR.PF>Hsap\MAPTScer\UAS.2N4R results in the disruption of the regular, crystalline array of ommatidia in the adult compound eye ranging from mild to severe. The severity of the disruption depends on the genomic insertion site of the transgene.
Hsap\MAPTUAS.2N4R, Scer\GAL4GMR.PF has visible phenotype, enhanceable by sggS9A.UAS, Scer\GAL4GMR.PF
Hsap\MAPTUAS.2N4R, Scer\GAL4GMR.PF has visible phenotype, enhanceable by Hsap\GSK3BUAS.cPa, Scer\GAL4GMR.PF
Hsap\MAPTUAS.2N4R, Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by l(3)87Df[+]/l(3)87Dfunspecified
Hsap\MAPTUAS.2N4R, Scer\GAL4GMR.PF has ommatidium phenotype, enhanceable by sggS9A.UAS, Scer\GAL4GMR.PF
Hsap\MAPTUAS.2N4R, Scer\GAL4GMR.PF has ommatidium phenotype, enhanceable by Hsap\GSK3BUAS.cPa, Scer\GAL4GMR.PF
Hsap\MAPTUAS.2N4R, Scer\GAL4GMR.PF has ommatidium phenotype, non-enhanceable by l(3)87Df[+]/l(3)87Dfunspecified
Co-expression of sggS9A.Scer\UAS and Hsap\MAPTScer\UAS.2N4R under the control of Scer\GAL4GMR.PF results in increased eye disruption relative to the expression of each transgene alone. The ommatidia are more severely disrupted and patches of pigment loss and glazing are visible in the eyes of the mutants.